Stenbolone

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Stenbolone
Stenbolone.svg
Clinical data
Synonyms2-Methyl-5α-androst-1-en-17β-ol-3-one; 2-Methyl-δ1-4,5α-dihydrotestosterone; 2-Methyl-δ1-DHT; Deacetylanatrofin
Routes of
administration
Intramuscular injection (as stenbolone acetate)
Drug classAndrogen; Anabolic steroid
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H30O2
Molar mass302.458 g·mol−1
3D model (JSmol)
  (verify)

Stenbolone is an anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which was never marketed.[1][2][3][4] A C17β ester prodrug of stenbolone, stenbolone acetate, is used as an AAS for depot intramuscular injection under the brand names Anatrofin and Stenobolone.[1][3]

Chemistry[edit]

Stenbolone, also known as 2-methyl-δ1-4,5α-dihydrotestosterone (2-methyl-δ1-DHT) or as 2-methyl-5α-androst-1-en-17β-ol-3-one, is a synthetic androstane steroid and a derivative of DHT.[1][3] It is closely related structurally to drostanolone (2-methyl-DHT), 1-testosterone1-DHT), and methylstenbolone (17α-methylstenbolone).[5]

Society and culture[edit]

Generic names[edit]

Stenbolone is the generic name of the drug and its INN.[1][3][4]

References[edit]

  1. ^ a b c d J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–. ISBN 978-1-4757-2085-3.
  2. ^ William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 301–. ISBN 978-0-9828280-1-4.
  3. ^ a b c d Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 962–. ISBN 978-3-88763-075-1.
  4. ^ a b I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 261–. ISBN 978-94-011-4439-1.
  5. ^ Rahnema CD, Crosnoe LE, Kim ED (2015). "Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem". Andrology. 3 (2): 150–5. doi:10.1111/andr.307. PMID 25684733.